コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 by centre and patient type (with vs without systemic lupus erythematosus).
2 haracteristic of autoimmune diseases such as systemic lupus erythematosus.
3 pressed in CD4(+) T cells from patients with systemic lupus erythematosus.
4 er of childhood and are also associated with systemic lupus erythematosus.
5 w-density granulocytes from individuals with systemic lupus erythematosus.
6 also been implicated in the pathogenesis of systemic lupus erythematosus.
7 d arthritis, inflammatory bowel disease, and systemic lupus erythematosus.
8 i-Goutieres syndrome and are associated with systemic lupus erythematosus.
9 n patients with autoimmune diseases, such as systemic lupus erythematosus.
10 neralized B cell hyperactivity, hallmarks of systemic lupus erythematosus.
11 mine the role of RAGE in the pathogenesis of systemic lupus erythematosus.
12 iseases such as rheumatoid arthritis (RA) or systemic lupus erythematosus.
13 mic juvenile idiopathic arthritis (SJIA) and systemic lupus erythematosus.
14 thrombocytopenia, rheumatoid arthritis, and systemic lupus erythematosus.
15 lly, DKK3 limited autoimmunity in a model of systemic lupus erythematosus.
16 y genetic C1q and C1r/C1s deficiencies cause systemic lupus erythematosus.
17 is a complication of the autoimmune disease systemic lupus erythematosus.
18 o the pathogenesis of the autoimmune disease systemic lupus erythematosus.
19 important genetic susceptibility regions for systemic lupus erythematosus.
20 trinsic TLR signaling in the pathogenesis of systemic lupus erythematosus.
21 mab which was recently approved for nonrenal systemic lupus erythematosus.
22 a major cause of morbidity and mortality in systemic lupus erythematosus.
23 ically overlaps with the autoimmune disorder systemic lupus erythematosus.
24 toantibody-producing autoreactive B cells in systemic lupus erythematosus.
25 t, including posttransplant vasculopathy and systemic lupus erythematosus.
26 ile idiopathic arthritis and childhood-onset systemic lupus erythematosus.
27 entral role in the molecular pathogenesis of systemic lupus erythematosus.
28 receptor dysfunction and is associated with systemic lupus erythematosus.
29 g type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus.
30 in animal models of rheumatoid arthritis and systemic lupus erythematosus.
31 assessment of disease activity and damage in systemic lupus erythematosus.
32 s anti-nuclear Abs, in an inducible model of systemic lupus erythematosus.
33 is a potentially devastating complication of systemic lupus erythematosus.
34 utative causal variants for association with systemic lupus erythematosus.
35 n of TLRs contributes to the pathogenesis of systemic lupus erythematosus.
36 otide polymorphisms that are associated with systemic lupus erythematosus.
37 egy for autoantibody-driven diseases such as systemic lupus erythematosus.
38 hat it may be a viable therapeutic target in systemic lupus erythematosus.
39 erosclerosis, inflammatory bowel disease and systemic lupus erythematosus.
40 nce to the use of BAFF-targeted therapies in systemic lupus erythematosus.
41 ies was found in AA, autoimmune uveitis, and systemic lupus erythematosus.
42 oth healthy individuals and in patients with systemic lupus erythematosus.
43 nity in a classic mouse model of spontaneous systemic lupus erythematosus.
44 ing plasmablasts/PCs in patients with active systemic lupus erythematosus.
45 ctivation of intracellular innate sensors in systemic lupus erythematosus.
46 body-associated disease in a murine model of systemic lupus erythematosus.
47 is (23 [26.7%]), psoriasis (18 [20.9%]), and systemic lupus erythematosus (12 [14.0%]) were the most
48 liliter) and than the level in patients with systemic lupus erythematosus (1346+/-1011 pg per millili
49 sis, 6 had inflammatory bowel disease, 2 had systemic lupus erythematosus, 2 had multiple sclerosis,
50 ti-DNA antibodies that are characteristic of systemic lupus erythematosus, a chronic autoimmune disea
52 tte smoking (aHR, 1.9; 95% CI, 1.1-3.4), and systemic lupus erythematosus (aHR, 3.5, 95% CI, 1.1-11).
53 are linked with autoimmune diseases such as systemic lupus erythematosus, Aicardi-Goutieres syndrome
54 plant recipients with a primary diagnosis of systemic lupus erythematosus, all of whom were enrolled
55 more, we examined B cells from patients with systemic lupus erythematosus, an autoimmune disorder wit
57 cells of human autoimmune diseases including systemic lupus erythematosus and Crohn's disease, and re
58 l non-Mendelian disorders, most particularly systemic lupus erythematosus and dermatomyositis, are al
59 story was remarkable for an aunt who died of systemic lupus erythematosus and for a brother with arth
60 quently in some autoimmune diseases, such as systemic lupus erythematosus and multiple sclerosis.
61 associated with autoimmune diseases such as systemic lupus erythematosus and neuromyelitis optica, a
62 active plasma cells (PCs), are a hallmark of systemic lupus erythematosus and play a key role in dise
64 and co-inhibitory pathways in two systemic (systemic lupus erythematosus and rheumatoid arthritis) a
65 nt of several autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis.
66 pathology of autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis.
67 iquitous RNA-binding La Ag often targeted in systemic lupus erythematosus and Sjogren's syndrome.
68 llinated H1 in 6% of sera from patients with systemic lupus erythematosus and Sjogren's syndrome.
69 to be up-regulated in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthropathy, an
70 f generalized autoimmune diseases, including systemic lupus erythematosus and systemic sclerosis.
71 st notably the alpha interferon signature of systemic lupus erythematosus and the interleukin-1 signa
73 e, such as atherosclerosis, type-2 diabetes, systemic lupus erythematosus, and rheumatoid arthritis.
75 ed aplastic anemia (AA), autoimmune uveitis, systemic lupus erythematosus, and sickle cell disease, r
76 is a disfiguring and common manifestation in systemic lupus erythematosus, and the etiology of this p
77 ared the results with those in patients with systemic lupus erythematosus, ankylosing spondylitis, an
78 dy-based therapies for rheumatoid arthritis, systemic lupus erythematosus, antineutrophil cytoplasmic
79 roiditis, Crohn disease, ulcerative colitis, systemic lupus erythematosus, antiphospholipid syndrome,
80 uch as Aicardi-Goutieres syndrome and severe systemic lupus erythematosus are generally lethal disord
82 rheumatic diseases rheumatoid arthritis and systemic lupus erythematosus, as well as the spondyloart
83 sclerosis unexpectedly increased, whereas in systemic lupus erythematosus, atacicept was beneficial.
85 a controversial role in the pathogenesis of systemic lupus erythematosus, but the underlying mechani
86 omplement component C3 have been reported in systemic lupus erythematosus, but their molecular mechan
88 cluding Aicardi-Goutieres syndrome (AGS) and systemic lupus erythematosus, can arise when TREX1 funct
89 cluding type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, celiac disease, Crohn's di
90 temic lupus erythematosus patient cells, and systemic lupus erythematosus cells with high IFN signatu
91 oach and will help exclude disorders such as systemic lupus erythematosus, common variable immunodefi
92 Immune complex-mediated diseases, such as systemic lupus erythematosus, commonly affect the kidney
93 line diffusion values from all patients with systemic lupus erythematosus correlated positively with
94 the serum of the systemic autoimmune disease systemic lupus erythematosus correlating with disease ac
98 correlation of these diffusivities with the systemic lupus erythematosus disease activity index are
99 pus erythematosus correlated positively with systemic lupus erythematosus disease activity index scor
101 shown that patients with prostate cancer and systemic lupus erythematosus exhibit reduced DNase I act
102 d that BND cells obtained from patients with systemic lupus erythematosus exhibited increased CD45 ac
106 cytoplasmic antibody-associated vasculitis, systemic lupus erythematosus, idiopathic pulmonary fibro
107 member, is implicated in the pathogenesis of systemic lupus erythematosus in human patients and murin
108 di-Goutieres syndrome and syndromic forms of systemic lupus erythematosus, including familial chilbla
110 n severity of human rheumatoid arthritis and systemic lupus erythematosus, indicating that increased
122 ent, as FcgammaRIIB-deficient mice develop a systemic lupus erythematosus-like disease at a markedly
124 llagen vascular/autoimmune disorders such as systemic lupus erythematosus; lymphoproliferative disord
125 D20 (rituximab)-mediated B cell depletion in systemic lupus erythematosus may be related to the absen
126 e disorders, including rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and ty
129 ype I IFN-driven autoimmune diseases such as systemic lupus erythematosus or psoriasis, but pDCs are
131 und that TBK1 gene expression is elevated in systemic lupus erythematosus patient cells, and systemic
133 t PP2A expression is increased in T cells of systemic lupus erythematosus patients and that this incr
139 w that atypical NKs purified from spleens of systemic lupus erythematosus-prone mice, and identified
140 re associated with type I diabetes mellitus, systemic lupus erythematosus, RA, and celiac disease, th
141 at newer composite responder indices such as Systemic Lupus Erythematosus Responder Index (SRI) and B
142 netic causes of an autoimmune disease called systemic lupus erythematosus reveals a new twist on an o
143 a) diseases, and autoimmune disorders (e.g., systemic lupus erythematosus, rheumatoid arthritis).
144 uss the current and future impact of AMDs on systemic lupus erythematosus, rheumatoid arthritis, and
145 they also cause autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and
146 emic autoimmune connective tissue disorders: systemic lupus erythematosus, rheumatoid arthritis, syst
148 e diseases, such as rheumatoid arthritis and systemic lupus erythematosus, show a polygenic inheritan
150 notyped to determine their associations with systemic lupus erythematosus (SLE) and clinical manifest
151 i-C1q) are frequently found in patients with systemic lupus erythematosus (SLE) and correlate with th
152 toantibody-containing serum from humans with systemic lupus erythematosus (SLE) and from a mouse mode
153 Human C1q deficiency is associated with systemic lupus erythematosus (SLE) and increased suscept
154 ded in the peripheral blood of patients with systemic lupus erythematosus (SLE) and lupus-prone mice.
155 pe across UBE2L3 is strongly associated with systemic lupus erythematosus (SLE) and many other autoim
156 on (IFN) system is persistently activated in systemic lupus erythematosus (SLE) and many other system
157 increased susceptibility for development of systemic lupus erythematosus (SLE) and other autoimmune
159 odies target the RNA binding protein Ro60 in systemic lupus erythematosus (SLE) and Sjogren's syndrom
160 autoantigen in autoimmune disorders such as systemic lupus erythematosus (SLE) and Sjogren's syndrom
161 um IL-23 and IL-23 receptor in patients with systemic lupus erythematosus (SLE) as compared with heal
163 onsidered to be the major IFNalpha source in systemic lupus erythematosus (SLE) but their phenotype a
171 etermine whether children born to women with systemic lupus erythematosus (SLE) have an increased ris
173 ed cohorts have demonstrated that women with systemic lupus erythematosus (SLE) have fewer live birth
174 tients with the autoimmune rheumatic disease systemic lupus erythematosus (SLE) have multiple defects
203 The increased risk of overall malignancy in systemic lupus erythematosus (SLE) is well established.
204 aneous lupus erythematosus (CLE) who develop systemic lupus erythematosus (SLE) may have few and mild
205 e population-based studies have been done on systemic lupus erythematosus (SLE) mortality trends in t
208 is and an autoimmune response reminiscent of systemic lupus erythematosus (SLE) occurs in its absence
209 on chr10p12.31 was replicated in a cohort of systemic lupus erythematosus (SLE) patients (N = 47) and
210 ved that skin-derived endothelial cells from systemic lupus erythematosus (SLE) patients expressed CD
212 ccessibility landscape of naive B cells from Systemic Lupus Erythematosus (SLE) patients undergoing d
213 mbers of ARID3a(+) B cells in nearly half of systemic lupus erythematosus (SLE) patients, and total n
214 Circulating levels of leptin are elevated in systemic lupus erythematosus (SLE) patients, but it is n
217 l loci have been found to be associated with systemic lupus erythematosus (SLE) susceptibility by a r
218 e multi-protein NADPH oxidase (NADPHO), with systemic lupus erythematosus (SLE) susceptibility in ind
219 ied more than 50 robust loci associated with systemic lupus erythematosus (SLE) susceptibility, and f
220 ional outcome of 39 variants associated with Systemic Lupus Erythematosus (SLE) through the integrati
221 samples from large cohorts of patients with systemic lupus erythematosus (SLE) with and without LN a
222 e variety of inflammatory diseases including systemic lupus erythematosus (SLE), Aicardi-Goutieres sy
223 ed in the serum and tissues of patients with systemic lupus erythematosus (SLE), an autoimmune disord
224 tibodies in MRL/lpr mice, which are prone to systemic lupus erythematosus (SLE), and inhibited the an
225 nodeficiency (CVID), Evans syndrome (ES), or systemic lupus erythematosus (SLE), and most achieved a
226 lls are implicated in the autoimmune disease systemic lupus erythematosus (SLE), but little is known
227 y complex (MHC) locus is well established in systemic lupus erythematosus (SLE), but the causal funct
228 pathogenesis in autoimmune diseases, such as systemic lupus erythematosus (SLE), but the natural hist
229 lay a critical role in autoimmunity, such as systemic lupus erythematosus (SLE), by helping B cells.
230 e pathogenesis of autoimmunity, most notably systemic lupus erythematosus (SLE), diabetes mellitus, a
233 ear the gene ETS1, have been associated with systemic lupus erythematosus (SLE), or lupus, in indepen
234 with several autoimmune diseases, including systemic lupus erythematosus (SLE), Sjogren's syndrome,
236 data from a genome-wide association study of systemic lupus erythematosus (SLE), we observed a single
238 s also linked to autoimmune diseases such as systemic lupus erythematosus (SLE), where nucleic acid-c
239 DLDs) and choroidal changes in patients with systemic lupus erythematosus (SLE), with or without glom
240 ferative glomerulonephritis, which resembled systemic lupus erythematosus (SLE)-like autoimmune disea
241 yeloid cells (LysM(Cre)Bim(fl/fl)) develop a systemic lupus erythematosus (SLE)-like disease that mir
280 ic variants are associated with the risk for systemic lupus erythematosus (SLE); however, it is uncle
281 plicated in the inflammation associated with systemic lupus erythematosus (SLE); however, it remains
283 The presence of autoreactive IgE in human systemic lupus erythematosus subjects was also associate
284 dren, such as juvenile idiopathic arthritis, systemic lupus erythematosus, systemic scleroderma, mixe
285 t the genesis of autoimmune diseases such as systemic lupus erythematosus, thyroiditis, and rheumatic
286 for investigating NMDA receptor function in systemic lupus erythematosus, traumatic brain injury, an
287 of multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes, and asthm
288 signals generated by sera from patients with systemic lupus erythematosus using this device showed go
290 from patients with rheumatoid arthritis and systemic lupus erythematosus were demethylated compared
291 7-mediated model of autoimmunity, similar to systemic lupus erythematosus, where both cell types are
292 capacity of macrophages in diseases such as systemic lupus erythematosus, where impaired phagocytosi
293 the study; however, 1 participant developed systemic lupus erythematosus while on study and was excl
294 al alterations in the brain of patients with systemic lupus erythematosus with and without a history
295 y of the corpus callosum of 13 patients with systemic lupus erythematosus with past NPSLE, 16 patient
297 comparisons were made between patients with systemic lupus erythematosus with/without past NPSLE and
298 is one of the most severe manifestations of systemic lupus erythematosus, with considerable morbidit
299 sociated with autoimmune diseases, including systemic lupus erythematosus, with risk correlating with
300 thematosus with past NPSLE, 16 patients with systemic lupus erythematosus without past NPSLE, and 19
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。